Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

679 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Therapeutic modulation of k-ras signaling in colorectal cancer.
Krens LL, Baas JM, Gelderblom H, Guchelaar HJ. Krens LL, et al. Among authors: gelderblom h. Drug Discov Today. 2010 Jul;15(13-14):502-16. doi: 10.1016/j.drudis.2010.05.012. Epub 2010 Jun 2. Drug Discov Today. 2010. PMID: 20594936 Review.
[Imatinib, a specific tyrosine-kinase inhibitor, for the treatment of patients with a gastrointestinal stroma cell tumor].
Gelderblom H, Hogendoorn PC, van der Graaf WT, Verweij J. Gelderblom H, et al. Ned Tijdschr Geneeskd. 2003 Oct 18;147(42):2051-5. Ned Tijdschr Geneeskd. 2003. PMID: 14606351 Review. Dutch.
Survival after adjuvant 5-FU treatment for stage III colon cancer in hereditary nonpolyposis colorectal cancer.
de Vos tot Nederveen Cappel WH, Meulenbeld HJ, Kleibeuker JH, Nagengast FM, Menko FH, Griffioen G, Cats A, Morreau H, Gelderblom H, Vasen HF. de Vos tot Nederveen Cappel WH, et al. Among authors: gelderblom h. Int J Cancer. 2004 Apr 10;109(3):468-71. doi: 10.1002/ijc.11712. Int J Cancer. 2004. PMID: 14961589
Pharmacology of oxaliplatin and the use of pharmacogenomics to individualize therapy.
Kweekel DM, Gelderblom H, Guchelaar HJ. Kweekel DM, et al. Among authors: gelderblom h. Cancer Treat Rev. 2005 Apr;31(2):90-105. doi: 10.1016/j.ctrv.2004.12.006. Cancer Treat Rev. 2005. PMID: 15847979 Review.
Skeletal retention of bisphosphonate (pamidronate) and its relation to the rate of bone resorption in patients with breast cancer and bone metastases.
Cremers SC, Papapoulos SE, Gelderblom H, Seynaeve C, den Hartigh J, Vermeij P, van der Rijt CC, van Zuylen L. Cremers SC, et al. Among authors: gelderblom h. J Bone Miner Res. 2005 Sep;20(9):1543-7. doi: 10.1359/JBMR.050522. Epub 2005 May 31. J Bone Miner Res. 2005. PMID: 16059626
Effect of milk thistle (Silybum marianum) on the pharmacokinetics of irinotecan.
van Erp NP, Baker SD, Zhao M, Rudek MA, Guchelaar HJ, Nortier JW, Sparreboom A, Gelderblom H. van Erp NP, et al. Among authors: gelderblom h. Clin Cancer Res. 2005 Nov 1;11(21):7800-6. doi: 10.1158/1078-0432.CCR-05-1288. Clin Cancer Res. 2005. PMID: 16278402
Small molecule tyrosine kinase inhibitors in the treatment of solid tumors: an update of recent developments.
Steeghs N, Nortier JW, Gelderblom H. Steeghs N, et al. Among authors: gelderblom h. Ann Surg Oncol. 2007 Feb;14(2):942-53. doi: 10.1245/s10434-006-9227-1. Epub 2006 Nov 14. Ann Surg Oncol. 2007. PMID: 17103252 Review.
[Long-term beneficial effects of cetuximab in a woman with metastasised rectal carcinoma without expression of the epidermal growth factor receptor].
Kroep JR, Gelderblom H, Collen AF, Nortier JW. Kroep JR, et al. Among authors: gelderblom h. Ned Tijdschr Geneeskd. 2006 Nov 18;150(46):2555-9. Ned Tijdschr Geneeskd. 2006. PMID: 17152334 Dutch.
Hepatic artery infusion of high-dose melphalan at reduced flow during isolated hepatic perfusion for the treatment of colorectal metastases confined to the liver: a clinical and pharmacologic evaluation.
van Iersel LB, Verlaan MR, Vahrmeijer AL, van Persijn van Meerten EL, Tijl FG, Sparidans RW, Gelderblom H, Kuppen PJ, Tollenaar RA, van de Velde CJ. van Iersel LB, et al. Among authors: gelderblom h. Eur J Surg Oncol. 2007 Sep;33(7):874-81. doi: 10.1016/j.ejso.2007.02.022. Epub 2007 Apr 2. Eur J Surg Oncol. 2007. PMID: 17400422
Insights into the role of heritable genetic variation in the pharmacokinetics and pharmacodynamics of anticancer drugs.
Pander J, Gelderblom H, Guchelaar HJ. Pander J, et al. Among authors: gelderblom h. Expert Opin Pharmacother. 2007 Jun;8(9):1197-210. doi: 10.1517/14656566.8.9.1197. Expert Opin Pharmacother. 2007. PMID: 17563256 Review.
679 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback